Coates, L., Garrood, T., Gullick, N., Helliwell, P., Kent, T., Marks, J., . . . McInnes, I. (2022). Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Oxford University Press.
Lua i Stíl Chicago (17ú heag.)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
Lua MLA (9ú heag.)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.